Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012 Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …
News

GSK appoints two non-executive directors to its Board

May 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …
Appointment

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …
Appointment

Pfizer enters Gaucher disease market

May 3, 2012 Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …
News

Professional regulation – a DIY job?

May 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Feature
Ian Read

Lipitor losses hit Pfizer

May 2, 2012 Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …
News

Targacept cuts workforce

May 1, 2012 Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
News

EMA eSubmission Gateway now live

May 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …
News
Press release

Actelion boosted by trial success

April 30, 2012 Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …
News
Votrient image

FDA approves GSK’s Votrient for new licence

April 30, 2012 Sales and Marketing Cancer, FDA Approval, GSK, Votrient

The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …
News

New ABPI president appointed

April 30, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …
Appointment
FDA picture

FDA approves new erectile dysfunction drug

April 30, 2012 Sales and Marketing ED, FDA, Stendra. Pfizer, Vivus, viagra

The FDA has approved Vivus’ erectile dysfunction drug Stendra, and the firm hopes its rapid mode of action will help …
News
Benlysta image

NICE no to GSK’s lupus drug Benlysta

April 27, 2012 Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE

NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly.  In its final …
News
screen_shot_2012-04-27_at_10

Novartis right to challenge NHS on Avastin use – ABPI chief

April 27, 2012 Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD

The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …
News

New head at Bayer’s Animal Health division

April 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …
Appointment
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026